Hashimoto’s In Remission (I’ll Tell You How I Got There)

Hashimoto’s Can Be Reversed or Put into Remission

For years, I sat in doctors’ offices being told the same thing in different words: manage it, monitor it, medicate it. Hashimoto’s thyroiditis was framed as a permanent condition — my immune system had turned on my thyroid, and the best I could hope for was to slow the damage and replace the hormones it could no longer adequately produce.

I never accepted that and I refused to medicate. And then I started asking a question nobody had ever asked me:

Why is my immune system attacking my thyroid in the first place? I didn’t believe God’s creation was confused and turning on itself! My next post will be titled Autoimmune: Your Body Isn’t Attacking Itself. You will want to stay tuned for that!

That question changed everything.

I am writing this for every person sitting in that same chair, being told the same thing, wondering if this is simply their life now. It doesn’t have to be. I know because I am not in remission by luck or by accident. I am in remission because I found the drivers of my autoimmunity and addressed them one by one. And I want to tell you exactly how I got there.

What Conventional Medicine Gets Wrong

Conventional medicine is excellent at diagnosing Hashimoto’s. TPO antibodies, TgAb antibodies, TSH, thyroid ultrasound — the diagnostic framework is sound and reliable.

What it fails at is the response.

The standard of care is: monitor TSH, prescribe levothyroxine when the number rises high enough, adjust the dose over time. The question of why the immune system is attacking the thyroid is treated as clinically irrelevant. The attack is accepted as a permanent feature of the patient’s biology — something to manage around, never something to investigate or resolve. I want to be clear I am not telling anyone not to take thyroid medication. That was my personal choice to choose supplements instead.

This is not individual physician failure. It is structural. There is no pharmaceutical solution to clearing a molecular mimicry trigger or healing a leaky gut. There is no drug company funding research into whether Yersinia eradication normalizes TPO antibodies. The standard of care reflects what gets funded and reimbursed — not what the biology makes possible.

And the biology makes significantly more possible than most patients are ever told.

The Root Causes Nobody Tests For

Hashimoto’s is not a random immune misfire. In my own case, there are identifiable drivers — triggers that initiated the autoimmune response and perpetuators that kept it running. Find them. Remove them. The immune system stops attacking.

Here are the ones that matter most:

Molecular Mimicry from Infections — The Most Important and Least Discussed

This is where Hashimoto’s most often begins and most often persists.

Molecular mimicry occurs when a pathogen produces surface proteins structurally similar to body tissues. The immune system learns to attack the pathogen — and then keeps attacking the body’s own tissue because it looks like what it was trained to fight. The infection may be long gone. The immune attack continues.

Yersinia enterocolitica contains surface proteins that resemble TSH receptor proteins on thyroid cells. Multiple published studies confirm elevated Yersinia antibodies in Hashimoto’s patients. The immune response to this gut bacteria cross-reacts directly with thyroid tissue.

Helicobacter pylori (H. pylori) operates through a similar mechanism. Published studies show that successful H. pylori eradication is associated with significant TPO antibody reduction — in some cases normalization. The stomach bacteria was the trigger the entire time.

Epstein-Barr Virus (EBV) maintains a state of chronic immune activation in those with recurrent reactivation. This sustained immune hyperactivation perpetuates autoimmune attacks on multiple tissues including the thyroid.

In my own case, I had all three drivers when diagnosed. So I got to work clearing all three! These are three documented driver of Hashimoto’s.

Intestinal Permeability — The Foundation

Dr. Alessio Fasano’s research established that intestinal permeability is a prerequisite for autoimmune disease. When the gut barrier breaks down, undigested proteins and bacterial antigens enter systemic circulation. The immune system encounters what it was never meant to encounter. Through molecular mimicry, it begins attacking self-tissue.

For Hashimoto’s, healing the gut removes the constant antigenic stimulus perpetuating the immune attack. This is not optional. It is foundational.

Nutritional Deficiencies

Selenium is the cofactor for the enzymes that convert T4 to active T3 and for the glutathione peroxidase enzymes protecting thyroid cells from oxidative damage. Multiple randomized controlled trials show selenium supplementation reduces TPO antibodies by 30-50% in Hashimoto’s patients.

Myo-Inositol is a second messenger in the TSH receptor signaling cascade. Without adequate myo-inositol, the thyroid doesn’t respond efficiently to TSH stimulation. Combined with selenium, published Italian RCTs show not only antibody reduction but meaningful improvement in Free T3 and Free T4.

Vitamin D is an immune regulator specifically affecting T-regulatory cells — the immune cells responsible for preventing autoimmune attacks. Low vitamin D is found consistently in Hashimoto’s patients. Optimization reduces antibodies in published studies.

Zinc is required for T3 receptor activation. Without it, the thyroid hormone that is produced cannot signal properly at the cellular level.

Mold and Chronic Stress

Mycotoxin exposure from mold disrupts immune regulation, damages gut barrier integrity, and creates the inflammatory environment in which autoimmunity establishes and persists. For those with mold exposure history like me, addressing the mold legacy is a necessary part of the resolution pathway.

Chronic stress and HPA axis dysfunction disrupt the immune regulation that healthy cortisol rhythms provide. An HPA axis in dysfunction allows autoimmune processes to run unchecked.

The Published Evidence That Resolution Is Possible

I want to be precise because this matters. The published literature doesn’t typically use the word “resolution” — the studies weren’t designed to test that outcome. But the evidence of meaningful, significant antibody reduction — in some cases to normal range — is there for those willing to look.

Selenium + Myo-Inositol: Multiple Italian randomized controlled trials show the combination produces significant TPO and TgAb reduction alongside Free T3 and Free T4 improvement. Some subjects achieved antibody levels within normal range.

H. Pylori Eradication: Published case series and studies show that successful H. pylori treatment in infected Hashimoto’s patients produces significant antibody reduction — in some cases complete normalization of TPO antibodies. A bacterial infection was the autoimmune trigger.

Vitamin D Optimization: Multiple published studies show inverse relationships between vitamin D levels and thyroid antibodies, and prospective studies show antibody reduction with optimization to therapeutic levels.

Selenium Alone: Cochrane reviews and meta-analyses confirm that selenium supplementation consistently and significantly reduces TPO antibody levels. This is among the most replicated findings in Hashimoto’s research.

AIP (Autoimmune Protocol) Diet: Published trials show meaningful antibody reduction with dietary elimination protocols that remove inflammatory triggers and support gut healing — directly addressing the intestinal permeability mechanism.

None of these studies promise resolution for every patient. Together they demonstrate that the autoimmune process driving Hashimoto’s is not a fixed, unresponsive biological fact. It responds to what drives it being removed.

What Resolution Actually Looks Like

Remission and resolution are not the same thing. The distinction matters enormously.

Remission: Symptoms controlled. Patient probably feels well. Antibodies are normal. Thyroid function maintained with glandular supplement or pharmaceutical support. Bloodwork would most likely no longer suggest Hashimoto’s.

Resolution: The autoimmune process has completely resolved:

TPO antibodies below 10 IU/mL — approaching undetectable
TgAb below 1.0 IU/mL — truly negative
TSH 1.0-1.8 mIU/L — pituitary-thyroid communication efficient
Free T4 1.0-1.3 ng/dL — thyroid producing independently
Free T3 3.2-4.0 pg/mL — upper range, efficient conversion
These values maintained without thyroid glandular or pharmaceutical support after a successful taper

I am currently in sustained remission trending toward resolution. I tell you this not to imply it was easy or fast. My remission has taken years of systematic, patient work. I tell you because transparency about the real timeline — and the real ongoing work — is what patients deserve when they ask whether this is possible.

Below: This was when I was in Year ONE of being in remission. I felt a lot of hope!

The Protocol Framework

This is not a single protocol applied identically to everybody — the drivers are individual and must be tested for. But the framework is consistent:

Test for molecular mimicry triggers: Yersinia antibodies (IgG and IgA), H. pylori (stool antigen or breath test), comprehensive EBV panel including EA-D IgG.

Heal the gut: Remove gluten (minimum 3-month trial), L-Glutamine 5-10g daily, spore-based probiotics alongside standard strains, bone broth daily, slippery elm, digestive enzymes.

Address identified triggers: H. pylori through mastic gum or medical eradication. Yersinia through biofilm disruption (EDTA, NAC), antimicrobial rotation (oregano oil, colloidal silver). EBV through L-Lysine, beta glucan, NK cell support including Mitopure.

Thyroid-specific nutrition: One Brazil nut daily for selenium, myo-inositol 600-900mg daily, zinc 15-25mg, vitamin D optimized to 50-80 ng/mL, vitamin K2 alongside D.

Support immune regulation: HPA axis repair if stress or steroid history is present. Adaptogens. Omega-3 fatty acids. Anti-inflammatory dietary foundation.

Monitor antibody trajectory every 3-6 months: The direction of change matters as much as the absolute value. TPO and TgAb declining consistently over 12-24 months is the target.

Consider glandular or pharmaceutical taper: Only when Free T4 is consistently 1.0-1.3 ng/dL and antibodies are approaching normal range — and only gradually, with careful monitoring.

Why Most Practitioners Don’t Explain This

I understand why the clinical conversation around Hashimoto’s stays where it does. The evidence for complete resolution — every antibody fully normal, all thyroid function restored without any support — is real but not as definitive as the evidence for significant improvement. A cautious clinician appropriately doesn’t promise outcomes that haven’t been proven for every patient.

But there is a profound difference between appropriate caution and failing to share what the evidence actually shows. And there is a difference between not promising resolution and not pursuing it.

Every Hashimoto’s patient deserves to know: the autoimmune process driving this condition has identifiable causes. Those causes respond to being addressed. The published evidence supports meaningful improvement and in some cases normalization of the very markers that define the disease.

I am living proof that the question is worth asking. My remission didn’t come from accepting permanent management. It came from refusing to stop asking why — and then systematically finding and removing every answer.

If you have Hashimoto’s, I want that for you too.

I am not a physician, discuss all medical advice with your doctor. Never start a new diet, or supplements without speaking to them first.